NEW HAVEN, Conn.–(BUSINESS WIRE)–Jan 21, 2021– Rallybio LLC, a clinical-stage biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with
NEW HAVEN, Conn.–(BUSINESS WIRE)–Jan 21, 2021– Rallybio LLC, a clinical-stage biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with